5-(Piperidin-1-yl)pentanoic acid hydrochloride, 95.0%, 5g

2-(2-Methoxyethyl)-4-methylpyridine, 250mg

3-(3-Methylphenyl)-5-phenyl-1,2,4-oxadiazole, 5g

2-(Pyrimidin-5-yl)acetonitrile, 95.0%, 100mg

Isopropyl palmitate, min. 90%, for synthesis, 1 l, plastic packaging.

7-Chloro-1,3-dioxaindane-5-carboxylic acid, 95%, 250mg

2-Fluoro-3-(trifluoromethyl)pyridine, 98.0%, 5g

1-(2-Chloroethyl)pyrrolidine, 98+%, 25g

Quinoxalin-2-ylmethanamine, 95+%, 1g

(1R,2R)-N,N'-(Cyclohexane-1,2-diyl)bis(2-(diphenylphosphino)benzamide), 98%, 5g

2,2'-(2,5-Dimethoxy-1,4-phenylene)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane), 98%, 25g

((4-(Bromomethyl)phenyl)sulfonyl)(4-(trifluoromethoxy)phenyl)amine, 98%, 10g

4-(1H-Pyrrol-1-yl)benzohydrazide, 95.0%, 1g